Moolec Science SA Stock Performance

MLEC Stock   9.90  -0.11  -1.10%   
Moolec Science holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.96, which alludes to a somewhat significant risk relative to the market. Market upswings tend to lift Moolec Science more than average, but downturns carry a proportionally larger impact on returns. Moolec Science SA semi variance, kurtosis, and the relationship between the value at risk and day typical price, to analyze future returns on Moolec Science SA.
Risk-Adjusted Performance
Moderate
 
Weak
 
Strong
Moolec Science SA currently ranks below 10% of comparable global equities and portfolios when recent risk-adjusted returns are measured across a 90-day horizon. The business is commonly classified in the Healthcare sector and the Biotechnology industry. In spite of rather conflicting technical and fundamental indicators, Moolec Science exhibited solid returns over the last few months and may actually be approaching a breakup point. Learn More

Actual Historical Performance (%)

 One Day Return
0.6
 Five Day Return
1.83
 Year To Date Return
141.79
 Ten Year Return
-99.32
 All Time Return
-99.32
 Last Split Factor
1:15
 Last Split Date
2026-01-05
Begin Period Cash Flow53 M
Total Cashflows From Investing Activities-36 M
Free Cash Flow-30.1 M

Relative Risk vs. Return Landscape

If you had invested $ 501.00 in Moolec Science SA on December 18, 2025 and sold it today you would have earned a total of $ 488.50 from holding Moolec Science SA or generated 97.5% return on investment over 90 days. Moolec Science SA is currently generating a 2.9519% daily expected return and carries 22.2126% risk (volatility on return distribution) over a 90-day horizon. In different words, most equities are less risky than Moolec, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
This comparison focuses on expected return, realized volatility, and risk efficiency versus the market. It is most useful when expected return is read together with volatility rather than in isolation. Given the investment horizon of 90 days Moolec Science is expected to generate 27.72 times more return on investment than the market. However, the company is 27.72 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of risk.

Target Price Odds to finish over Current Price

Investors have long observed that Moolec Stock price tends to fluctuate around a central value over time. This mean reversion pattern is a cornerstone of many forecasting models. However, periods of persistent mispricing in some stocks suggest that additional risk factors may account for the delayed correction.
Current PriceHorizonTarget PriceOdds moving above the current price in 90 days
9.90 90 days 9.90
about 25.31
A normal distribution analysis suggests that the odds of Moolec Science moving above the current price in 90 days from now are about 25.31 (The distribution above shows where Moolec Stock price is most likely to fall within the next 90 days based on historical volatility).
Given the investment horizon of 90 days the stock has the beta coefficient of 2.96 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Moolec Science will likely underperform. In addition to that, Moolec Science SA has an alpha of 2.3872, implying that it can generate a 2.3872 percent excess return over Dow Jones Industrial after adjusting for the inherent market risk (beta).
   Moolec Science Price Density   
       Price  

Predictive Modules for Moolec Science

Forecasting Moolec Science SA involves applying various models to estimate future price behavior. While no method can consistently predict the stock market with certainty, the discipline of building and testing forecasts sharpens investment thinking. Combining several approaches and cross-checking results offers a more balanced view of potential outcomes.
Mean reversion in Moolec Science's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Hype
Prediction
LowEstimatedHigh
0.479.4031.61
Details
Intrinsic
Valuation
LowRealHigh
0.326.3728.58
Details
Naive
Forecast
LowNextHigh
0.157.6729.88
Details
Analyst
Consensus
LowTargetHigh
2.733.003.33
Details
A rigorous investment case for Moolec Science requires more than studying its own financials. Benchmarking Moolec Science's performance, valuation, and risk profile against competitors is essential to validate any investment thesis.

Primary Risk Indicators

The stock market has gone through extended periods of turbulence over the past two decades. Moolec Science has not been immune to these swings. Sudden corrections and sharp rallies have tested many portfolios. Investors can protect against downside risk in Moolec Science SA by monitoring Moolec Science's fundamental risk indicators and maintaining appropriate hedges.
α
Alpha over Dow Jones
2.39
β
Beta against Dow Jones2.96
σ
Overall volatility
3.73
Ir
Information ratio 0.11

Investor Alerts and Insights

Setting up alerts on Moolec Science ensures that material changes in technical or fundamental conditions are not missed. These notifications for Moolec Science SA help investors make timely decisions in response to significant stock events.
Moolec Science SA is way too risky over 90 days horizon
Moolec Science SA appears to be risky and price may revert if volatility continues
Moolec Science SA has high likelihood to experience some financial distress in the next 2 years
The company reported previous year's revenue of 333.61 M. Net Loss for the year was -111.46 M with loss before overhead, payroll, taxes, and interest of -639.5 K.
Moolec Science generates negative cash flow from operations
About 21.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders Equity Requirement - marketscreener.com

Price Density Drivers

The interaction between bullish and bearish market participants is a primary driver of near-term price dynamics. The future price of Moolec Stock reflects these dynamics, along with broader investor sentiment. Moolec Science's short-sentiment indicators are presented below.
Common Stock Shares Outstanding430.9 K
Cash And Short Term InvestmentsM

Moolec Science Fundamentals Growth

Moolec Science's fundamentals serve as the primary lens through which investors evaluate Moolec Stock. Metrics such as earnings growth, revenue consistency, margin trends, and balance sheet strength collectively determine market sentiment toward Moolec Stock.

Performance Metrics & Calculation Methodology

Moolec Science performance is measured on a risk-adjusted basis against benchmarks. Drawdown profile frames downside sensitivity and recovery characteristics. Moolec Science shows ROE of -1.75%, ROA of -21.69%.

This section for Moolec Science SA is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Analyst projections are included when active coverage applies. Values may update on different source schedules. Return and risk statistics are calculated from historical price series.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 22nd, 2026